Based on its recent analysis of the breast imaging systems market, Frost and Sullivan recognizes Gamma Medica with the 2014 Global Frost and Sullivan Award for Product Leadership.

A handful of new genetic variants point to Parkinson’s disease, the National Institutes of Health (NIH) announced yesterday. The six previously unreported risk factors will contribute to researchers’ understanding as they work to develop better treatments for the neurodegenerative disease.

The industry for Alzheimer’s drug treatments is expected to grow from modest beginnings to big business in the next decade, according to a June report by Decision Resources Group.

A novel, non-invasive molecular imaging technique uses nanotechnology to allow clinicians a view into the gastrointestinal track without having to resort to invasive procedures, according to a study published July 6 in Nature Nanotechnology.

Selection of patients with advanced prostate cancer who are eligible for salvage radiation therapy could be improved with the use of radiocholine PET/CT, according to a review of recent research published today in the Journal of Nuclear Medicine.

The Centers for Medicare & Medicaid Services provided a reiteration of the agency’s national coverage decision regarding oncologic FDG PET this summer and clarified specifically the –KX modifier that needs to be used when clinicians code for the fourth scan and beyond.

Nematode worms are providing a very, very small window on the neural connections that we humans share. A feature in New Scientist follows the circuitous path of our knowledge about consciousness and the neural networks of the brain.

A feature in The New Yorker explores how Daniela Schiller, PhD, from the Mount Sinai School of Medicine’s Brain Imaging Core in New York City, has approached a kind of memory erasure for people who have suffered greatly from post-traumatic stress disorder (PTSD) with the aid of cutting-edge neuroimaging.